Related Experiment Videos

Nitric oxide: inducer or suppressor of apoptosis?

P Nicotera¹, B Brune, G Bagetta

¹Faculty of Biology, University of Konstanz, Germany.

Trends in Pharmacological Sciences

|June 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety.

Frontiers in pharmacology·2023

2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022

NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022

Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022

Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2021

Eptinezumab for the treatment of migraine.

Drugs of today (Barcelona, Spain : 1998)·2019

See all related articles